- Home
- CRVS vs AVNW Comparison
CRVS vs AVNW Comparison
Compare CRVS & AVNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- AVNW
- Stock Information
- Founded
- CRVS 2014
- AVNW 2006
- Country
- CRVS United States
- AVNW United States
- Employees
- CRVS N/A
- AVNW N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- AVNW Radio And Television Broadcasting And Communications Equipment
- Sector
- CRVS Health Care
- AVNW Technology
- Exchange
- CRVS Nasdaq
- AVNW Nasdaq
- Market Cap
- CRVS 305.4M
- AVNW 274.4M
- IPO Year
- CRVS 2016
- AVNW 2007
- Fundamental
- Price
- CRVS $5.55
- AVNW $23.19
- Analyst Decision
- CRVS Strong Buy
- AVNW Strong Buy
- Analyst Count
- CRVS 4
- AVNW 5
- Target Price
- CRVS $15.00
- AVNW $37.60
- AVG Volume (30 Days)
- CRVS 461.1K
- AVNW 86.6K
- Earning Date
- CRVS 08-07-2025
- AVNW 10-03-2025
- Dividend Yield
- CRVS N/A
- AVNW N/A
- EPS Growth
- CRVS N/A
- AVNW N/A
- EPS
- CRVS N/A
- AVNW N/A
- Revenue
- CRVS N/A
- AVNW $435,926,000.00
- Revenue This Year
- CRVS N/A
- AVNW $8.50
- Revenue Next Year
- CRVS N/A
- AVNW $5.18
- P/E Ratio
- CRVS N/A
- AVNW N/A
- Revenue Growth
- CRVS N/A
- AVNW 14.58
- 52 Week Low
- CRVS $2.54
- AVNW $12.96
- 52 Week High
- CRVS $10.00
- AVNW $28.37
- Technical
- Relative Strength Index (RSI)
- CRVS 69.70
- AVNW 56.97
- Support Level
- CRVS $5.03
- AVNW $21.00
- Resistance Level
- CRVS $5.81
- AVNW $22.30
- Average True Range (ATR)
- CRVS 0.32
- AVNW 0.81
- MACD
- CRVS 0.09
- AVNW 0.11
- Stochastic Oscillator
- CRVS 85.22
- AVNW 97.14
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About AVNW Aviat Networks Inc.
Aviat Networks Inc is a networking solutions provider. It designs, manufactures and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.